Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
Core EBITDA Growth

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results

DR LAL PATHLABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 27.63-13.3225.7722.3217.38

What is the latest Core EBITDA Growth ratio of DR LAL PATHLABS ?

The latest Core EBITDA Growth ratio of DR LAL PATHLABS is 27.63 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202427.63
Mar2023-13.32
Mar202225.77
Mar202122.32
Mar202017.38

How is Core EBITDA Growth of DR LAL PATHLABS Trending?

Years Core EBITDA Growth % Change
Mar2024 27.63
Positive
Mar2023 -13.32
Negative
Mar2022 25.77
15.46
Mar2021 22.32
28.42
Mar2020 17.38 -

Other Financial Ratios of DR LAL PATHLABS


Compare Core EBITDA Growth ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹22,669.0 Cr -2.9% -3.4% 13.2% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹99,197.4 Cr -13% -6.1% 22.6% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹90,799.3 Cr -9.1% -5.8% 5.2% Stock Analytics
FORTIS HEALTHCARE ₹46,463.9 Cr -8.3% -7.3% 44.5% Stock Analytics
GLOBAL HEALTH ₹29,982.4 Cr -3.3% 8.2% -11.1% Stock Analytics
NARAYANA HRUDAYALAYA ₹27,730.7 Cr -0.1% 5.1% 1.2% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

-2.9%

-3.4%

13.2%

SENSEX

-2.9%

-0.1%

6.8%


You may also like the below Video Courses